Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126964231 | 12696423 | 1 | I | 20160817 | 20160830 | 20160830 | EXP | CA-ORION CORPORATION ORION PHARMA-TREX2016-1479 | ORION | 0.00 | M | Y | 89.00000 | KG | 20160830 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126964231 | 12696423 | 1 | PS | METHOTREXATE (TRADE NAME UNKNOWN) | METHOTREXATE | 1 | Oral | U | 0 | ||||||||||
| 126964231 | 12696423 | 2 | SS | ENBREL | ETANERCEPT | 1 | Unknown | U | 0 | BIW | |||||||||
| 126964231 | 12696423 | 3 | SS | METHOTREXATE. | METHOTREXATE | 1 | Subcutaneous | U | 0 | SOLUTION FOR INJECTION | |||||||||
| 126964231 | 12696423 | 4 | SS | ANAKINRA | ANAKINRA | 1 | Unknown | U | 0 | ||||||||||
| 126964231 | 12696423 | 5 | SS | ARAVA | LEFLUNOMIDE | 1 | Oral | U | 0 | 10 | MG | TABLET | QD | ||||||
| 126964231 | 12696423 | 6 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | U | 0 | ||||||||||
| 126964231 | 12696423 | 7 | SS | HYDROXYCHLOROQUINE | HYDROXYCHLOROQUINE | 1 | Unknown | U | 0 | ||||||||||
| 126964231 | 12696423 | 8 | SS | NAPROSYN | NAPROXEN | 1 | Oral | U | 0 | 500 | MG | BID | |||||||
| 126964231 | 12696423 | 9 | SS | ORENCIA | ABATACEPT | 1 | Unknown | U | 0 | ||||||||||
| 126964231 | 12696423 | 10 | SS | RITUXIMAB | RITUXIMAB | 1 | Unknown | U | 0 | ||||||||||
| 126964231 | 12696423 | 11 | SS | VIOXX | ROFECOXIB | 1 | Unknown | U | 0 | ||||||||||
| 126964231 | 12696423 | 12 | C | XELJANZ | TOFACITINIB CITRATE | 1 | Unknown | 0 | |||||||||||
| 126964231 | 12696423 | 13 | C | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126964231 | 12696423 | 1 | Rheumatoid arthritis |
| 126964231 | 12696423 | 2 | Rheumatoid arthritis |
| 126964231 | 12696423 | 3 | Rheumatoid arthritis |
| 126964231 | 12696423 | 4 | Rheumatoid arthritis |
| 126964231 | 12696423 | 5 | Rheumatoid arthritis |
| 126964231 | 12696423 | 6 | Rheumatoid arthritis |
| 126964231 | 12696423 | 7 | Rheumatoid arthritis |
| 126964231 | 12696423 | 8 | Rheumatoid arthritis |
| 126964231 | 12696423 | 9 | Rheumatoid arthritis |
| 126964231 | 12696423 | 10 | Rheumatoid arthritis |
| 126964231 | 12696423 | 11 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126964231 | 12696423 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126964231 | 12696423 | Abdominal discomfort | |
| 126964231 | 12696423 | Acne cystic | |
| 126964231 | 12696423 | Drug ineffective | |
| 126964231 | 12696423 | Drug intolerance | |
| 126964231 | 12696423 | Insomnia | |
| 126964231 | 12696423 | Rheumatoid arthritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |